Importantly, however, HIF-2a inhibition did not significantly affect DLK1-mediated stem cell marker expression under normoxic conditions, suggesting that there are other mediators downstream of DLK1 that can contribute to DLK1 signaling in glioma. This evidence concerns the gene EPAS1 and glioma.